Hematologic/Lymphatic

15-79%
Strong

for lymphatic malformations and hereditary lymphedema with exome/genome sequencing

System Profile

Yield Comparison

Clinical Dimensions

  • Recurrent infections
  • Chronic lymphadenopathy
  • Cytopenias
  • Bleeding issues
  • Failure to thrive with infections
  • SCID
  • Chronic granulomatous disease
  • Wiskott-Aldrich
  • HLH
  • Periodic fever syndromes
  • Congenital neutropenias
  • Pallor
  • Petechiae
  • Easy bruising
  • Lymphadenopathy
  • Hepatosplenomegaly
  • Chronic eczema
  • Mucosal bleeding
  • Recurrent oral ulcers
  • Frequent infections
  • Easy bruising
  • Recurrent nosebleeds
  • Prolonged fevers
  • Chronic fatigue after mild infections
  • Pancytopenia
  • Neutropenia
  • Lymphopenia
  • Thrombocytopenia
  • Abnormal immunoglobulins
  • Very high ferritin
  • Elevated soluble IL-2 receptor
  • Inflammatory markers without infection
  • CT/MRI showing persistent lymphadenopathy
  • Splenomegaly
  • Marrow infiltration
  • Thymic hypoplasia
  • Organomegaly with cytopenias
  • Flow cytometry showing T/B/NK cell deficits
  • Bone marrow biopsy with HLH features
  • Immunoglobulin panels abnormal
  • Neutrophil oxidative burst test abnormal (CGD)
  • Chronic antibiotics
  • IVIG or SCIG
  • Long-term steroids or immunosuppressants for cytopenias or HLH
  • Frequent transfusions
  • Severe drug reactions causing marrow suppression or cytopenias
  • Recurrent DRESS or SJS/TEN in context of genetic predisposition
  • Splenectomy
  • Lymph node biopsies
  • Port placement for chronic transfusions or chemo
  • Thymectomy
  • Education and support for chronic infections
  • Transfusion planning
  • Immune monitoring
  • Port-a-cath for transfusions
  • Splenectomy prophylaxis tools
  • Home infusion equipment
  • Hematology/oncology for cytopenias, immune cytopenias, HLH
  • Lymphoproliferative disease clinics
  • Heme expressing concern for inherited immune/bleeding disorder
  • Cytopenias
  • Early leukemias/lymphomas
  • Recurrent fevers
  • Periodic fever syndromes
  • Autoimmune cytopenias in family
  • No crowding, daycare, or obvious exposure explaining recurrent infections
  • Siblings also affected
  • Infections occur despite good care and nutrition
  • Recurrent early infections
  • Omphalitis
  • Neonatal sepsis
  • Lymphadenopathy or splenomegaly
  • Unexplained cytopenias in newborn period

Red Flag Combinations

Clinical patterns that should prompt consideration of genetic testing

Recurrent infections + eczema + thrombocytopenia
Cytopenias + hepatosplenomegaly + fevers
Periodic fevers + serositis
Recurrent infections + failure to thrive

Screening Decision Pathway

When to consider genetic testing for hematologic/lymphatic presentations

        graph TD
          START["Patient Presents with\nHematologic/Lymphatic Concerns"] --> SCREEN{"Screen for\nRed Flags"}
          
          SCREEN --> RF1["Newborn CBC or infection screens with cytopenias"]
          
          SCREEN --> RF2["PCP infection-risk tools flagging recurrent severe..."]
          
          
          RF1 --> EVAL{"Multiple\nFlags Present?"}
          
          RF2 --> EVAL{"Multiple\nFlags Present?"}
          
          EVAL -->|Yes| TEST["Order Genetic Testing\n(ES/GS)"]
          EVAL -->|No| MONITOR["Continue Monitoring\nRe-evaluate if New Findings"]
          TEST --> DX["Molecular Diagnosis\n15-79% yield"]
          style TEST fill:#dcfce7,stroke:#16a34a,color:#14532d
          style DX fill:#bbf7d0,stroke:#16a34a,color:#14532d
          style MONITOR fill:#fef3c7,stroke:#d97706,color:#92400e
        

Screening Red Flags

Findings on routine screening that may indicate genetic etiology

  • Newborn CBC or infection screens with cytopenias
  • PCP infection-risk tools flagging recurrent severe infections

Exome / Genome Sequencing Indications

Clinical scenarios supporting ES/GS as a diagnostic approach

  • Recurrent or severe infections
  • Cytopenias
  • HLH
  • Immune dysregulation without clear cause
  • Negative first-line PIDD panel
  • Strong family clustering

Key Evidence

Published studies supporting genetic testing for hematologic/lymphatic conditions

Study Year Type Sample Yield Key Finding
PIK3CA-related overgrowth spectrum: review of vascular manif... 2021 Review None None Comprehensive review of PIK3CA-related overgrowth spectrum with focus on vascula...
cfDNA NGS liquid biopsy for AVM molecular diagnosis 2020 Cohort 5 None Cell-free DNA NGS liquid biopsy detects somatic variants in arteriovenous malfor...
cfDNA NGS for Maffucci syndrome 2022 Case Report 1 None Cell-free DNA next-generation sequencing successfully detects IDH1 somatic varia...
Clinical and molecular spectrum of sporadic venous malformat... 2022 Cohort 43 None Molecular characterization of sporadic venous malformations identifies TEK/TIE2 ...
Genetic causes of vascular malformations 2022 Review None None Comprehensive review of genetic causes of vascular malformations across PI3K/AKT...
RAS pathway variants in disorders of somatic mosaicism 2022 Cohort 938 None RAS pathway somatic variants characterized in 938 patients with disorders of som...
NGS panel for AVM evaluation 2023 Cohort 54 68.5% 68.5% somatic variant detection using targeted NGS panel for arteriovenous malfo...
HHT somatic second-hit mutations in telangiectasia and AVM 2024 Cohort 14 None Somatic second-hit mutations identified in HHT lesional tissue supporting two-hi...
Updated: 2026-02-25 Curated by: human Status: human reviewed